Denosumab discontinuation in non-metastatic breast cancer treated with AI raises vertebral fracture riskDenosumab discontinuation in non-metastatic breast cancer treated with AI raises vertebral fracture risk
Aromatase inhibitors (AIs) are a cornerstone of adjuvant therapy for hormone receptor–positive breast cancer, significantly reducing recurrence and mortality. However, by suppressing estrogen production, AIs accelerate bone loss and increase fracture risk. To counter this, antiresorptive therapies such as denosumab or bisphosphonates are widely recommended.
FDA Approves Semaglutide Pill for ObesityFDA Approves Semaglutide Pill for Obesity
This Medical News article discusses the US Food and Drug Administration approval of oral semaglutide for the treatment of obesity in adults. This Medical News article discusses the US Food and Drug Administration approval of oral semaglutide for the treatment of obesity in adults.
GLP-1 Receptor Agonists Plus Progestins and Endometrial Cancer RiskGLP-1 Receptor Agonists Plus Progestins and Endometrial Cancer Risk
This cohort study compares the associations of glucagon-like peptide-1 (GLP-1) receptor agonists and of progestins with risk of endometrial cancer among US women with endometrial hyperplasia or other benign uterine pathologies. This cohort study compares the associations of glucagon-like peptide-1 (GLP-1) receptor agonists and of progestins with risk of endometrial cancer among US women with Read More
Hims pulls cheaper Wegovy pill after federal scrutinyHims pulls cheaper Wegovy pill after federal scrutiny
Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal officials raised concerns that the product may violate drug laws. Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal officials Read More
STAT+: Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patentSTAT+: Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patent
Novo Nordisk has filed a lawsuit accusing Hims & Hers of infringing on a key patent for its widely sold Wegovy weight loss treatment, a new legal tactic by the drugmaker as it tries to thwart compounded versions of its big-selling medicine. Specifically, Novo Nordisk claims the telehealth platform infringed on the patent for semaglutide, Read More
How associations between historical redlining and breast cancer survival changed over timeHow associations between historical redlining and breast cancer survival changed over time
A 1930s to 1960s residential segregation policy has been linked to shorter survival time in people with breast cancer. New research reveals that this association has changed over time, with disparities narrowing until recently. The findings are published in Cancer.
You’ve reached your weight loss goal on GLP-1 medications. What now?You’ve reached your weight loss goal on GLP-1 medications. What now?
GLP-1 drugs have ushered in a new era in weight loss. GLP-1 drugs have ushered in a new era in weight loss.
Teddi Mellencamp refuses famous father’s plea to move home to Indiana during cancer fightTeddi Mellencamp refuses famous father’s plea to move home to Indiana during cancer fight
“Real Housewives” star and “The Masked Singer” contestant Teddi Mellencamp opens up about her stage four melanoma recovery and why she won’t leave LA despite her famous father’s wishes.
STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of WegovySTAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
The Department of Health and Human Services asked the Department of Justice to investigate Hims & Hers for potentially violating federal law over its plan to make a compounded version of a low-cost weight loss pill widely available on its telehealth platform, according to a social media post by HHS general counsel Mike Stuart. The Read More
3D-Printed Breast Tissue; Cancer and Ultraprocessed Food; Agent Orange and Melanoma3D-Printed Breast Tissue; Cancer and Ultraprocessed Food; Agent Orange and Melanoma
(MedPage Today) — Bioengineered tissue produced with a 3D printer could offer a reconstruction solution that “allows a woman to be whole again” after breast cancer surgery. (CNN)
Aging in fast forward: A husband-caregiver documents his wife’s…